Back to RXRX
PDS Planning, Inc RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
4
Latest value
$100K
Q3 2026
Peak value
$100K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $56K |
| Q1 2026 | $74K |
| Q2 2026 | $89K |
| Q3 2026 | $100K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $100K | 24.3K | — | — |
| Q2 2026 | $89K | 24.2K | — | — |
| Q1 2026 | $74K | 24.2K | — | — |
| Q4 2025 | $56K | 13.7K | — | — |